Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
NASA counts down for first crewed lunar mission in half a century - 2Germany and trade unions kick off tough public-sector wage talks
- 3Gulf countries roll out more autonomous taxis
- 4RFK Jr.'s handpicked vaccine panel just voted to stop recommending hepatitis B shots for all newborns. Why experts object.
- 5Gulf countries continue to face Iran attacks as criticial energy infrastructure at risk
- Israel's ban on unsupervised reporters in Gaza causes strategic harm to legitimacy
- 4 Home Rec center Hardware Decisions for Little Spaces
- Poll: Only 25% of Americans think Trump has 'followed through' on his promise to release the Epstein files
- European nations criticise Israel’s death penalty plans
- Moscow: Russia well-positioned to withstand oil market shocks
- Trump signs a law returning whole milk to school lunches
- How AI fixed the James Webb Space Telescope's blurry vision
- Disability rights activist and author Alice Wong dies at 51
- The most effective method to Really Adjust Hypothesis and Practice in Your Brain science Studies
